Association between race and survival of patients with non-small-cell lung cancer in the united states veterans affairs population

Clinical Lung Cancer

Volumn 15, Issue 2, 2014, Pages 152-158

  Ganti, Apar Kishor ^a,b   Subbiah, Shanmuga P ^a,b,c   Kessinger, Anne ^b   Gonsalves, Wilson I ^c   Silberstein, Peter T ^a,c   Loberiza, Fausto R ^b  

^a VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Non small cell lung cancer; Outcomes; Prognosis; Race; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; AGED; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; CONFERENCE PAPER; DEMOGRAPHY; FEMALE; HEALTH CARE SYSTEM; HEALTH DISPARITY; HEALTH INSURANCE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; OVERALL SURVIVAL; POPULATION RESEARCH; RACE DIFFERENCE; RETROSPECTIVE STUDY; SMOKING; UNITED STATES; VERY ELDERLY; VETERAN; YOUNG ADULT; ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; ETHNOLOGY; FOLLOW UP; LUNG NEOPLASMS; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; UNITED STATES; VETERANS; YOUNG ADULT;

EID: 84894052887     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2013.11.004     Document Type: Conference Paper

References (29)

1. A. Jemal, R. Siegel, and E. Ward et al. Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. J.H. Stewart Lung carcinoma in African Americans: a review of the current literature Cancer 91 2001 2476 2482
3. S.M. Gadgeel, and G.P. Kalemkerian Racial differences in lung cancer Cancer Metastasis Rev 22 2003 39 46
4. W.R. Carpenter, L.M. Beskow, and D.E. Blocker et al. Towards a more comprehensive understanding of cancer burden in North Carolina: priorities for intervention N C Med J 69 2008 275 282
5. A.W. Blackstock, J.E. Herndon 2nd, and E.D. Paskett et al. Outcomes among African-American/non-African-American patients with advanced non-small-cell lung carcinoma: report from the Cancer and Leukemia Group B J Natl Cancer Inst 94 2002 284 290
6. R.S. Higgins, C. Lewis, and W.H. Warren Lung cancer in African Americans Ann Thorac Surg 76 2003 S1363 S1366
7. C.R. Mulligan, A.D. Meram, and C.D. Proctor et al. Unlimited access to care: effect on racial disparity and prognostic factors in lung cancer Cancer Epidemiol Biomarkers Prev 15 2006 25 31
8. C.S. Lathan, B.A. Neville, and C.C. Earle The effect of race on invasive staging and surgery in non-small-cell lung cancer J Clin Oncol 24 2006 413 418
9. L.R. Shugarman, K. Mack, and M.E. Sorbero et al. Race and sex differences in the receipt of timely and appropriate lung cancer treatment Med Care 47 2009 774 781
10. D. Hardy, R. Xia, and C.C. Liu et al. Racial disparities and survival for nonsmall-cell lung cancer in a large cohort of black and white elderly patients Cancer 115 2009 4807 4818
11. D. Hardy, C.C. Liu, and R. Xia et al. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer Cancer 115 2009 2199 2211
12. K.L. Schwartz, H. Crossley-May, and F.D. Vigneau et al. Race, socioeconomic status and stage at diagnosis for five common malignancies Cancer Causes Control 14 2003 761 766
13. C.S. Lathan, C. Okechukwu, and B.F. Drake et al. Racial differences in the perception of lung cancer: the 2005 Health Information National Trends Survey Cancer 116 2010 1981 1986
14. P.B. Bach, L.D. Cramer, and J.L. Warren et al. Racial differences in the treatment of early-stage lung cancer N Engl J Med 341 1999 1198 1205
15. C.J. Neighbors, M.L. Rogers, and E.D. Shenassa et al. Ethnic/racial disparities in hospital procedure volume for lung resection for lung cancer Med Care 45 2007 655 663
16. C.C. Earle, L.N. Venditti, and P.J. Neumann et al. Who gets chemotherapy for metastatic lung cancer? Chest 117 2000 1239 1246
17. H.P. Greenwald, N.L. Polissar, and E.F. Borgatta et al. Social factors, treatment, and survival in early-stage non-small cell lung cancer Am J Public Health 88 1998 1681 1684
18. D.R. Lewis, L.X. Clegg, and N.J. Johnson Lung disease mortality in the United States: the National Longitudinal Mortality Study Int J Tuberc Lung Dis 13 2009 1008 1014
19. A.S. Bryant, and R.J. Cerfolio Impact of race on outcomes of patients with non-small cell lung cancer J Thorac Oncol 3 2008 711 715
20. F. Farjah, D.E. Wood, and N.D. Yanez 3rd et al. Racial disparities among patients with lung cancer who were recommended operative therapy Arch Surg 144 2009 14 18
21. M.V. Graham, L.M. Geitz, and R. Byhardt et al. Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer J Natl Cancer Inst 84 1992 1731 1735
22. J.D. Hunt, A. Strimas, and J.E. Martin et al. Differences in KRAS mutation spectrum in lung cancer cases between African Americans and Caucasians after occupational or environmental exposure to known carcinogens Cancer Epidemiol Biomarkers Prev 11 2002 1405 1412
23. R.S. Leidner, P. Fu, and B. Clifford et al. Genetic abnormalities of the EGFR pathway in African American Patients with non-small-cell lung cancer J Clin Oncol 27 2009 5620 5626
24. S.H. Yang, L.E. Mechanic, and P. Yang et al. Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer Clin Cancer Res 11 2005 2106 2110
25. J.M. Reinersman, M.L. Johnson, and G.J. Riely et al. Frequency of EGFR and KRAS mutations in lung adenocarcinomas in African Americans J Thorac Oncol 6 2011 28 31
26. M.L. Cote, R. Haddad, and D.J. Edwards et al. Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer J Thorac Oncol 6 2011 627 630
27. C. Mascaux, N. Iannino, and B. Martin et al. The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis Br J Cancer 92 2005 131 139
28. D.A. Eberhard, B.E. Johnson, and L.C. Amler et al. Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib J Clin Oncol 23 2005 5900 5909
29. C.M. Tammemagi, C. Neslund-Dudas, and M. Simoff et al. Lung carcinoma symptoms-an independent predictor of survival and an important mediator of African-American disparity in survival Cancer 101 2004 1655 1663